Lessons from epidemiology: Summary of general discussion  by Oliver, Michael F.
JACC Vol. 5. No.6
June 1985:1558-1568
Lessons From Epidemiology: Summary of General Discussion
Michael F. Oliver, MD, FACC
1558
The section on epidemiology focused on the relation of risk
factors to sudden cardiac death and on the lack of impact
of intervention trials, whether instituted before or after the
onset of the clinical features of coronary heart disease , on
sudden cardiac death rates. Our knowledge about both themes
is weak because of the lack of agreement and uniformit y
concerning the best definition of sudden cardiac death and
because of the inaccuracies and inadequacies of current sys-
tems of data acquisition . If an operative definition of sudden
cardiac death as death within I hour of last being seen alive
were accepted worldwide, then much of the weakness in
trying to relate risk factors to sudden cardiac death or in
interpreting the result s of clinical trials would disappe ar.
As it is. there are only two approaches available to us.
One approach is to analyze the results of a particular epi-
demiologic study or a single clinical trial, because it may
be supposed that the degree of consistency in the definition
of sudden cardiac death in a given study is high , with the
weakness that the numbers of patients will inevitably be
small. The other approach is to analyze all existing epide-
miologic surveys and clinical trials on the assumption that
the inconsistency inherent in these methods with regard to
definition is unimportant. However, primary ventricular fi-
brillation can be distinguished temporally and mechani sti-
cally from reperfusion ventricular fibrillation , from ventric-
ular fibrillation occurring during profound vagal bradycardia
and also from ventricular fibrillation occurring much later
after the onset of the symptoms of a heart attack , during
excessive catecholamine stimulation of long duration and
incipient cardiac failure. Therefore , the inconsistencies in
the definition of sudden cardiac death are actually very im-
portant. I am bound to conclude that the data base on which
we are currently attempting to assess the relation of sudden
death to risk factors or the success or failure of clinical trials
is unacceptably poor.
Adding fuel to the fire, no nation has a sufficiently com-
prehensive system of recording sudden cardiac death (what-
ever the definition may be) so that trends may be monitored.
Would it be so difficult to introduce on death certificates
some statement such as " time of death after onset of relevant
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terminal symptoms" ? These weaknesses-no uniform def-
inition of sudden cardiac death and an unsatisfactory system
of acquiring data on sudden cardiac death-make it difficult
to assess with any confidence or perspective the actual re-
lation between risk factors and sudden cardiac death .
Dr. Kannel, quoting the Framingham experience. was
able to demonstrate various, rather weak relations between
different risk factors and sudden cardiac death, but both the
sensitivity and specificity of the relations are so low that
the presence of one or more than one risk factor cannot be
used to predict sudden cardiac death on a population basis,
let alone on an individual basis. Indeed , one of the important
recurring themes through this and previous discussions on
sudden cardiac death is our continuing inability to predict
impending sudden cardiac death. Even in patients with un-
stable angina , and surely this is the group from which the
information should come most readily, we are unable to
distinguish those who are likey to die within the following
week or two from those who will not.
And if we cannot predict . we cannot prevent. Surely we
should aim at providing preventive treatment acutely to those
with " incipient" ventricular fibrillation . Admittedly , some
victims of sudden cardiac death probably do not have pre-
ceding symptoms. Actually, we do not know this because
of the confounding problem that many such people do not
declare their symptoms to anyone or deny the significance
of the symptoms to themselves. If there are no premonitory
features identifiable, then a preventive impasse exists. But
many patients do have premonitory symptoms , and it is
from patient s with unstable angina that we ought to be able
to learn more . Primary and secondary prevention trials have
not had any impact on the incidence of sudden cardiac death
with the single exception of trials of beta-adrenergic block-
ing agents , and the results of these are impressive. Indeed,
the impact of beta-blocking therapy after myocardial in-
farction is probably greater on subsequent sudden cardiac
death than on recurrent myocardial infarction. But even
beta-blocking therapy has not been formally and adequately
studied in patients with unstable angina. It seems to me that
this is an ideal group of people to study because we already
know from the Edinburgh and Rotterdam studies that about
4% die within 3 months of the onset of their symptoms .
This is a high yield over a ShOJ1 time, which is ideal for
testing the effects of different preventive regimens .
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Althoughmanydifferent mechanisms leadto sudden car-
diac death, such as platelet/thrombus formation, rupture of
a plaque, spasm of a coronary artery and a sudden neuro-
genic efflux of catecholamines, one common denominator
is the metabolism of the potentially or actually ischemic
myocardium. The success of preventive therapy given acutely
to patients with unstable angina will depend on an improve-
ment in our knowledge of the metabolic and electrophysi-
ologic influences occurring at the time of the onset of ven-
tricular fibrillation. It is clear that inhomogeneity of blood
flow, electrolyte and substrate fluxes and conduction dif-
fusion are all critical and interrelated. Each presents pro-
foundly difficult problems for study, particularly since gra-
dients of inhomogeneity in any of these factors vary
substantially from minute to minute and it is likely that the
milieu present before the onset of ventricular fibrillation
(whatever the precipitating structural cause may be) is also
acute and transient. This makes the challenge all the greater.
Where should we place the emphasis? First it should be
on agreeing on and implementing internationally a compre-
hensive yet simplesystem of collecting data on sudden car-
diac death at the levels of death certificates, autopsies, reg-
isters and epidemiologic and clinical surveys.
Shouldwenotpay moreattention to the nutritional needs
of the potentially ischemic myocardium? I continue to be
impressed by the theoretical and actual benefits of decreas-
ing the free fatty acid/glucose availability ratio. For ex-
ample, if it were possible to provide all patients with un-
stable angina with the right nutritional and ionic balance, it
is conceivable that they might withstand the momentary
inhomogeneities leading to ventricular fibrillation. My an-
swer to Dr. Meijler's question "Why don't we all have
sudden cardiac death?" is that all who have advanced coro-
nary heart disease have this risk, but most are protected by
an adequately nourished myocardium. What we need to
learn more about is why and when does the myocardium
become inadequately nourished.
